Cross Sectional (2)

46
7/21/2019 Cross Sectional (2) http://slidepdf.com/reader/full/cross-sectional-2 1/46 Cross sectional (2)

description

v

Transcript of Cross Sectional (2)

Page 1: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 1/46

Cross sectional (2)

Page 2: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 2/46

Cross-Sectional

• Instead of looking at a ratio ofprevalences, we can also look at aratio of odds.

• Odds are not intuitively appealing:tey are te likeliood of an eventoccurring divided !y te likeliood of

te event not occurring.

Page 3: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 3/46

Cross-Sectional Studies

353588

88889595GrapGrap

ee

TomatoTomato

(+)(+)  --

DZ = RashDZ = Rash

 95/183

PR= ------- =2.68/43

Odds of grape work in rash pts:(95/ 103) / (8/ 103)= 95 / 8=11.9Odds of grape work in healthy:

(88/ 123) / (35/ 123)= 88 / 35=2.5 

183

43

103 123

Page 4: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 4/46

Cross-Sectional Studies

353588

88889595GrapGrap

ee

TomatoTomato

(+)(+)  --

DZ = RashDZ = Rash

 95/183

PR= ------- =2.68/43

Odds of grape work in rash pts: 95 / 8=11.9Odds of grape work in healthy: 88 / 35=2.5

Odds ratio=(95 / 8)/(88 / 35)=11.9/2.5=4.7

183

43

Page 5: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 5/46

Cross-Secto!a" St#$es

45050

%orma"&

'o

400100*h

%o CDCD

Cho"estero"

  100 & (100 + 400) 02,rea"e!ce Rato = --------------------- = ----= 20

  50 & (50 + 450) 01

Page 6: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 6/46

Cross-Secto!a" St#$es

  100 & (100 + 400) 02,rea"e!ce Rato = --------------------- =---- = 20

  50 & (50 + 450) 01

.!terpretato!/  .! ths st#$ pop#"ato!

the prea"e!ce o CD s 2 tmes h*her amo!* those th h*h cho"estero"

compare$ to the prea"e!ce ! those

th !orma" or "o cho"estero"

Page 7: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 7/46

Page 8: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 8/46

Cross-Secto!a" St#$

!e"ical exam # $%rays to "iagnose

osteoarthritis of the knee

steoarthrts

+ -

40 10

20 30

+

-     3     4    e    s          t    0

50

50

Page 9: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 9/46

Cross-Secto!a" St#$

&revalence of osteoarthritis amongobese s'b(ects: )0*+0 , 0-.

&revalence of osteoarthritis amongnon%obese s'b(ects: /0*+0 , 0-)

&revalence ratio , 0-.*0-) , /-0

Page 10: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 10/46

Cross-Secto!a" St#$

  Obese s'b(ects are to

times more likely to have

osteoarthritis of the knee

than non%obese s'b(ects-

Page 11: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 11/46

Cross-Secto!a" St#$

hat came first2

Obesity or Osteoarthritis

Chicken or eggdilemma

Page 12: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 12/46

Study "esign

•  #$ infectioninfection, sown !y a positive skintest, usually re%ains dor%ant.&owever, infected persons sould !e

treated wit I'& to prevent future #$

diseasedisease.

•  :: &ow can you deter%ine ow !ig a

pro!le% #$ infection is a%ong%igrant far% workers and if tere areany ig-risk su!groups

Page 13: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 13/46

Cross-Sectional Studies

• *n e+a%ple fro% te literature:

 #u!erculin reactivity a%ongCalifornia %igrant &ispanic far%workers.

Introduction:Introduction:• igrant far% workers at increased

risk for #$.

Page 14: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 14/46

Cross-Sectional Studies

• etods:etods:

• Study population all residents > 1 year of age

• Brief health and work questionnaire

• Tuberculin skin test (TST) for persons

not known to be TST(+)• Followup for TST(+) as needed

Page 15: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 15/46

Cross-Sectional Studies

•esultsesults•Se+

 – ales - 2/ (/0.1)

 –

3e%ales - 241 (14.5)•*ge

 – 25.6 7 85.8 y ( ean 7 S")

•9lace of !irt – .S. - 821 (24.5) – 'on-.S. - 0// (50.8)

Page 16: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 16/46

Cross-Sectional Studies

Page 17: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 17/46

Cross-Sectional Studies

Multivariate odds ratios for positive TB skin test

Page 18: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 18/46

Cross-Sectional Studies

• "iscussion"iscussion• Overall prevalence 84.4

• ;ower tan o!served in oter settings

• Increased prevalence for  – en (O 8.22)

 – 3S (O 0.88)

 – 81-06y (O 2.16)

 – 'on-S $orn (O 2.6)

Page 19: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 19/46

Cross-Sectional Studies

• "iscussion"iscussion

• Increased risk for. . .•   < en: as in oter studies

• = 81-06 yrs. < not seen in oter studies

• = 3S < not seen in oter studies

• = 'on-S $orn < as in oter studies

CRSS SCT.%6'

Page 20: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 20/46

2

CRSS-SCT.%6'

ST7D.S 

E- Sample selection by expos're

Example: orkers ith an" itho'texpos're to asbestos are compare" forthe sim'ltaneo's presence of l'ng cancer-

3- Sample selection by o'tcome

  Example: orkers "etermine" to have ornot have l'ng cancer at a point in time arecompare" for sim'ltaneo's expos're toasbestos

Page 21: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 21/46

28

  4- Sample selection neither by

o'tcome nor by expos're

  Example: 5ll orkers in a plant are

sim'ltaneo'sly assesse" both forasbestos expos're an" l'ng cancer

stat's-

6Sampling schemes 78 E an" 4 arelikely to be inefficient9 

Page 22: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 22/46

eare

The act that past e:pos#re a!$ hea"th$ata are co""ecte$ $oes !ot ma;e t a

retrospecte cohort st#$

The $st!cto! s that ! the cross-secto!a" st#$ o# start th peop"e

here the are !o

.! the retrospecte cohort st#$ o# start$e!t!* peop"e ! the past eore the

o#tcomes occ#rre$

. o# start th peop"e here the are!o some are mss!* rom the cohort

Page 23: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 23/46

as  o# *ot the ro!* a!ser

Se"ecto! as/ a"asco!s$er t ! cross-secto!a" st#$es

Page 24: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 24/46

Se"ecto! as ! cross-secto!a"Se"ecto! as ! cross-secto!a"

st#$esst#$es

• &ow did te people wo are participating in yourstudy get to !e were tey are >as it related toe+posure >as it related to disease

• *re tose wo ended up in your studyrepresentative of te source population Couldteir participation relate to e+posure Could it

relate to disease

•  o# sho#"$ !ot $o a cross-secto!a" st#$ o# sho#"$ !ot $o a cross-secto!a" st#$

tho#t po!$er!* ao#t the a!sers totho#t po!$er!* ao#t the a!sers to

these >#esto!sthese >#esto!s

Page 25: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 25/46

Sa%pling $ias in Cross-Sectional Studies

• .s st#$ pop#"ato! represe!tate o tar*etpop#"ato!? – Often use a non-pro!a!ility sa%ple: Convenience

sa%ple wit non-consecutive enroll%ent• .s there sstematc !crease or $ecrease o

cases? – ;engt-!iased sa%pling. Cases are

overrepresented if illness as long duration and areunderrepresented if sort duration (9 ? k + inc + t)

• .s there sstematc !crease or $ecrease o

e:pos#re? – 9revalence-incidence !ias. @+posure does not alterdisease risk, !ut alters disease duration.

•   ↑e+posure in cases if %ild disease eg, &;*-*2•   ↓e+posure in cases if rapidly fatal

" i St t i t i i i

Page 26: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 26/46

"esign Strategies to ini%iAeSa%pling $ias

• 9opulation-!ased sa%ple – 9ro!a!ility sa%ple – 'on-pro!a!ility sa%ple

se consecutive enroll%ent if conveniencesa%ple• *dBust for seasonal or oter ti%e-dependent

trends

Page 27: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 27/46

easure%ent $ias in Cross-Sectional Studies

Outco%e• isclassied (dead, %isdiagnosed, undiagnosed)

@+posure• "iDerential %isclassication due to recall !ias•  #i%e fro% e+posure i%portant indicator of

accuracy• 'eed etiologically relevant e+posure. se current

e+posure if: – @+posure is +ed eg, !lood type – ecent e+posure correlates well wit prior e+posure – ecall of prior e+posure unlikely to !e relia!le eg, diet

Page 28: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 28/46

Strategies to ini%iAeeasure%ent $ias

 – StandardiAe %easure%ent %etods

 – #rain and certify assessors

 – ene te instru%ents

 – Cali!rate te instru%ents

 – *uto%ate te instru%ents

 – ake uno!trusive %easures

 – 3or key varia!les, use data fro% E 8 source

 – $linding of su!Bect and o!server

I%ple%entation of tese strategies dependson i%portance of varia!le, potential eDectof inaccuracy, feasi!ility and cost.

" ' $ %

Page 29: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 29/46

cc#pato!a" 'ea$ %e#roto:ct/cc#pato!a" 'ea$ %e#roto:ct/

a ehaora" a!$a ehaora" a!$

e"ectrophso"o*ca" ea"#ato!e"ectrophso"o*ca" ea"#ato!

•  #o evaluate te eDects of cronic lead

e+posure on te nervous syste% in adults,a set of tests was ad%inistered to 66 leade+posed foundry e%ployees and 48une+posed workers.

•  #is is a cross-sectional study

Page 30: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 30/46

Page 31: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 31/46

 #ose workers wit te igest !lood lead concentrationswere

more tense

more angry more depressed more fatigued more confused 

and had less vigor tan tose wit low !lood lead

Se"ecto! as?

Who choose (or are chosen for) dirty jobs?

Who stay there?Who get dirtiest on the job?

Right: Those who are tense, angry, depressed, fatigued,

confused, and have lest vigor 

Page 32: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 32/46

Kelebihan Studi Potong Lintang:

• dapat untuk melihat distribusi frekwensi penyakit dipopulasi

• dapat untuk melihat hubungan variabel “exposure”dan variabel “outcome”

• hasil analisisnya dapat dipakai untuk membangun

hipotesis baru

 Kelemahan Studi Potong Lintang

• tidak dapat untuk melihat hubungan sebab akibat,

karena variabel “exposure” dan variabel “outcome”diukur secara simultan

Page 33: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 33/46

Cross-Secto!a" St#$esStre!*ths/

@ ,ro$es prea"e!ce estmates oe:pos#re a!$ $sease or a e""-$e<!e$ pop#"ato!

@ aser to perorm tha! st#$esthat re>#re o""o-#p (he!cere"ate" !e:pe!se)

@ Ca! ea"#ate m#"tp"e rs; (a!$protecte) actors a!$ hea"th

o#tcomes at the same po!t !

Page 34: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 34/46

Cross-Secto!a" St#$es

Stre!*ths/@ Aa $e!t *ro#ps o perso!s

at h*h or "o rs; o $sease

@ Ca! e #se$ to *e!eratehpotheses ao#t assocato!setee! pre$cte actors a!$$sease o#tcomes

Page 35: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 35/46

Cross-Secto!a" St#$es'mtato!s/

@ ,rea"e!t rather tha! !c$e!t(!e) cases are #se$ B thee:pos#re co#"$ e assocate$ th

s#ra" ater $sease occ#rre!cerather tha! $ee"opme!to the $sease

@ Tempora" se>#e!ce etee!e:pos#re a!$ $seaseca!!ot e esta"she$

Page 36: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 36/46

Cross-Secto!a" St#$

Dsa$a!ta*es/

@ EChc;e! or e**F $"emma B $o!ot ;!o hether the e:pos#re

prece$e$ $sease or as aco!se>#e!ce o $sease$ee"opme!t

Page 37: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 37/46

Cross-Secto!a" St#$

6$a!ta*es/

@ #c; eas a!$ cheap

@ Ca! st#$ m#"tp"e e:pos#res a!$$sease o#tcomes sm#"ta!eo#s"

@ Goo$ or $escr!* thema*!t#$e a!$ $str#to! ohea"th pro"ems

Page 38: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 38/46

Cross-secto!a" St#$es

• te! #se$ to st#$ co!$to!s that arere"ate" re>#e!t th "o!* $#rato! oe:presso! (!o!ata" chro!c co!$to!s)

• .t meas#res prea"e!ce !ot !c$e!ce o

$sease• :amp"e/ comm#!t s#res

• %ot s#ta"e or st#$!* rare or h*h" ata"$seases or a $sease th short $#rato! oe:presso!

Page 39: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 39/46

Cross-secto!a" st#$es• Dsa$a!ta*es

• ea;est oserato!a" $es*!(t meas#res prea"e!ce !ot !c$e!ce

o $sease) ,rea"e!t cases are s#rors• The tempora" se>#e!ce o e:pos#re a!$eHect ma e $Ic#"t or mposs"e to

$eterm!e• 7s#a"" $o!Jt ;!o he! $sease occ#rre$• Rare ee!ts a pro"em #c;" emer*!*$seases a pro"em

Page 40: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 40/46

%ato!a" S#res

•6 "ar*e set o !ato!a"ep$emo"o*ca" s#res areco!$#cte$ the %ato!a"Ce!ter or ea"th Statstcs(%CS) --- the Ke$era"Goer!me!tJs pr!cpa" ta" a!$hea"th statstcs a*e!c

@ The %CS s part o the Ce!teror Dsease Co!tro" a!$

,ree!to! (CDC) B #!$er the

Page 41: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 41/46

%ato!a" S#res

•%ato!a" ea"th .!tere S#re(%.S),r!cpa" so#rce o !ormato! o!the hea"th o the c"a! !o!-!stt#to!a"Le$ ho#seho"$pop#"ato! o the 7S

@ %ato!a" ea"th a!$ %#trto!:am!ato! S#re (%6%S)Co""ects !ormato! ao#t the

hea"th a!$ $et o peop"e ! the

Page 42: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 42/46

%ato!a" S#res

• %ato!a" ea"th Care S#re(%CS)Co""ects a $e ra!*e o $ata

o! hea"th care #se mpact ome$ca" tech!o"o* a!$ >#a"to care pro$e$

@ %ato!a" .mm#!Lato! S#re(%.S)Co""ects !ormato! o! the

mm#!Lato! coera*e a!$

Page 43: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 43/46

%ato!a" S#res

• %ato!a" S#re o Kam" Groth(%SKG)Co""ects $ata o! actors aHect!*

pre*!a!c a!$ ome!Js hea"th !the 7S

@ %ato!a" Aorta"t Ko""oac;S#re (%AKS)6**re*ate samp"e o $eathcert<cates across the 7S or

tar ete$ research p#rposes

Page 44: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 44/46

%ato!a" S#res• %ato!a" Aater!a" a!$ .!a!t

ea"th S#re (%A.S)Co""ects $ata o! st#$ actorsre"ate$ to "o rthe*ht

st""rth !a!t ""!ess a!$!a!t $eath

@ ehaora" Rs; Kactor

S#re""a!ce SstemCo""ects $ata o! prea"e!ce operso!a" hea"th ehaors

amo!* a$#"ts assocate$ th

Page 45: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 45/46

%ato!a" S#res&,ro*rams

•  o#th Rs; ehaorS#re""a!ce SstemCo""ects $ata to mo!tor

prea"e!ce o ehaors !o#ths that res#"ts ! s*!<ca!tmorta"t mor$t $sa"ta!$ soca" pro"ems

@ %ato!a" ,ro*ram o Ca!cerRe*stres (%,CR)

@ S#re""a!ce p$emo"o* a!$

!$ Res#"ts (SR) ,ro*ram

Page 46: Cross Sectional (2)

7/21/2019 Cross Sectional (2)

http://slidepdf.com/reader/full/cross-sectional-2 46/46

ther So#rces o %ato!a" Data

• %ato!a" Mta" Statstcs Sstem--- rth $ata--- Aorta"t $ata

--- Keta" $eath $ata--- Aarra*es a!$$orces

--- '!;e$ rths&!a!t$eaths--- %ato!a" $eath !$e: